AzTrials
AzTrials

Healing WoundNCT05297071

Longitudinal Monitoring of Microsurgical Socket Augmentation Healing With Ultrasonography

A study testing Orascopic HDL 3.0 Loupes and Semorr DOM3000D Operation Microscope in people with Healing Wound, run by University of Michigan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess healing after tooth extraction with simultaneous socket augmentation (bone grafting during the same appointment as the extraction) when the surgeon uses a surgical microscope, compared to when the surgeon uses dental loupes (magnifiers that are mounted on the surgeon's glasses). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Healing Wound
What is being tested?
Orascopic HDL 3.0 Loupes and Semorr DOM3000D Operation Microscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
22 Mar 2022to 21 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • At least 18 years of age
  • Single maxillary or mandibular hopeless tooth (a maxillary or mandibular anterior tooth or premolar) planned for extraction due to periapical pathology with a minimum ≥2 mm of the size of the periapical radiolucency shown on a peri-apical film.
  • The patient is planned for implant restoration for the hopeless tooth
  • The study site allows for implant placement with or without additional bone augmentation procedures after the healing
  • Adequate edentulous space for the final restoration on the implant

Who cannot join

  • Current smokers or quit smoking less than 6 months
  • Major or uncontrolled medical conditions, e.g. poorly controlled diabetes mellitus (HbA1c >8.0%, uncontrolled systemic disease or condition known to alter bone metabolism, e.g. osteoporosis, osteopenia, hyperparathyroidism, Paget's disease, etc.
  • Pregnancy, breast-feeding, could be pregnant or planning to become pregnant in the next 4 months (self-reported)
  • Taking medications known to modify bone metabolism (i.e. bisphosphonates, corticosteroids, hormone replacement therapy)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Michigan School of Dentistry

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

Official title: Longitudinal Monitoring of Microsurgical Socket Augmentation Healing With Ultrasonography - A Randomized Controlled Trial

The purpose of this study is to assess healing after tooth extraction with simultaneous socket augmentation (bone grafting during the same appointment as the extraction) when the surgeon uses a surgical microscope, compared to when the surgeon uses dental loupes (magnifiers that are mounted on the surgeon's glasses). These devices magnify and shine light on the area where the surgeon operates.

Read the detailed description

After a tooth is extracted, a hole is left in the bone called a socket. During the first year of healing after a tooth extraction, there may be up to 60% loss of bone volume at the site. Loss of bone at the edentulous ridge (toothless area) may make it more difficult to place dental implants later. Dental socket grafting is performed to reduce bone resorption after tooth extraction. Grafting involves filling the socket with bone graft (donated human cadaver derived) and covering it with a protective collagen membrane. This graft prevents resorption of the ridge and is slowly replaced with the patient's own bone. The investigators will be trying to determine if bone healing is better if the surgeon uses more powerful magnification.

Conditions
Healing Wound
Being tested
Orascopic HDL 3.0 Loupes, Semorr DOM3000D Operation Microscope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Orascopic HDL 3.0 LoupesDevice

    The loupes will be used during the surgical procedure on half of the subjects. The other half will be performed with a microscope.

  • Semorr DOM3000D Operation MicroscopeDevice

    The microscope will be used during the surgical procedure on half of the subjects. The other half will be performed with loupes.

Study groups in NCT05297071
Study groupRoleWhat they receive
Dental LoupesOtherThe surgeon will use dental loupes with a head lamp during the subject's tooth extraction and socket grafting.
Receives: Device: Orascopic HDL 3.0 Loupes
Surgical microscopeOtherThe surgeon will use a surgical microscope (with built-in lighting) during the subject's tooth extraction and socket grafting.
Receives: Device: Semorr DOM3000D Operation Microscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone quality

    Difference in bone density from the CBCT and ultrasound

    Measured: 12 weeks

Secondary outcomes (1)
  1. Patient-reported outcomes

    Difference in patient-reported outcomes. Subjects will be given a questionnaire to evaluate pain perception, pain medication use, and complications after surgery.

    Measured: 1 week, 2 weeks, and 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Mar 2022
  2. Study start22 Mar 2022
  3. Primary completion26 Jun 2023
  4. Study completion21 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05297071
Sponsor's protocol ID
HUM00195615
Status last verified
Feb 2024
First submitted
16 Mar 2022
Last updated
28 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Orascopic HDL 3.0 Loupes and Semorr DOM3000D Operation Microscope in people with Healing Wound, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone quality (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in